Benjamin R. Yerxa, EVP & Chf, Research & Develop at INSPIRE PHARMACEUTICALS INC (ISPH), sold 6,125 shares at $4.94 ($31K) on 2009-06-15, disclosed to the SEC on 2009-06-16.
Open-market sale of $31k ISPH by EVP & Chf, Research & Develop. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.94 | 500 | $2K | 8.1% |
| 2 | $4.97 | 2,625 | $13K | 42.7% |
| 3 | $4.98 | 1,400 | $7K | 22.8% |
| 4 | $4.99 | 200 | $998 | 3.3% |
| 5 | $5.00 | 500 | $3K | 8.2% |
| 6 | $5.01 | 400 |
| $2K |
| 6.6% |
| 7 | $5.07 | 300 | $2K | 5.0% |
| 8 | $5.15 | 100 | $515 | 1.7% |
| 9 | $5.16 | 100 | $516 | 1.7% |
| Total | $4.99 avg | 6,125 | $31K | 100% |
| Filing → |
| IRD | BUY | 2024-11-25 | $10K | — | Filing → |
| CLSD | BUY | 2024-05-15 | $10K | — | Filing → |
| ISPH | SELL | 2010-05-05 | $13K | — | Filing → |